LETTERS IN DRUG DESIGN & DISCOVERY, cilt.16, sa.1, ss.36-44, 2019 (SCI-Expanded)
Background: A series of novel cinnamic acid piperazine amide derivatives has been designed and synthesized, and their biological activities were also evaluated as potential tyrosinase inhibitors.